TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

K TREATMENTS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

K TREATMENTS

ST13

US500000079400910

Classe

5, 42, 44

Pedido

79400910

Registro

7617332

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 42, 44

Data de depósito

13/10/2023

Data de registro

24/12/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/12/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

01

Localização do titular

IT

Examinador

BROWN, BARBARA TROFFKIN

Unidade examinadora

M70

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

P. A. (pessoa física)

Representantes

Daniel M. Gurfinkel Dennemeyer & Associates, LLC.

Classificação técnica

Classes Nice

Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Adjuvants for medical purposes; Medicinal healthcare preparations, namely, for the treatment of heavy metal detox, vaginal infections, inhalation allergies, pain, insomnia, hormonal disorders; Sanitary preparations for medical use; Food supplements; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Nutritional supplements; Vitamin supplements; Protein supplements; Diagnostic preparations for medical or veterinary purposes; Pharmaceuticals for the treatment of erectile dysfunction; Vitamins and vitamin preparations; quantum-medical preparations and bio-cybernetic pharmaceutical preparations for the treatment of heavy metal detox, vaginal infections, inhalation allergies, pain, insomnia, hormonal disorders and for hormonal system regulation; Medical preparations for slimming purposes; Nasal spray preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Anti-inflammatory preparations; Pharmaceutical preparations for suppressing tumors; tumor suppressing agents; Pharmaceutical preparations for the treatment of viral diseases; Vaginal moisturizers; Vaginal lubricants; Vaginal antifungals; Vaginal washes for medical purposes; Vaginal suppositories for the prevention and treatment of infections

Classe 42

Research in the field of quantum physics and quantum chemistry; Research in the field of quantum communication technology; Research and development in the medical and biotechnology fields; Research and development in the medical field for pain treatment; Consulting services in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research in the field of bio-cybernetic regulators; custom design of quantum electromagnetic transformers; custom design of quantum electromagnetic inductors; custom design of quantum electromagnetic transformers and electromagnetic inductors for pain treatment; Technical consultancy in relation to technical research in the field of food and beverages; Cosmetic research; Scientific research relating to cosmetics; resarch laboratory analysis in the field of cosmetics; Testing of cosmetics

Classe 44

Performing bio-cybernetic diagnosis of diseases; Health care services, namely, bio-cybernetics therapy; medical services; Performing diagnosis of diseases using quantum-mechanics; medical treatment using quantum-chemical and quantum-physical technology; Regenerative medicine services; Alternative medicine services; Health assessment services; Providing nutritional information about food; Consulting services in the fields of health and nutrition

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/02/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/02/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

24/12/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

24/12/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/07/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

18/06/2025

FIMP

FINAL DISPOSITION PROCESSED

18/06/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

25/03/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

24/12/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

24/12/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/11/2024

PUBO

PUBLISHED FOR OPPOSITION

05/11/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

16/10/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

27/09/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

27/09/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

27/09/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

27/09/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

27/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/09/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

24/09/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

24/09/2024

RFNT

REFUSAL PROCESSED BY IB

09/09/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

20/08/2024

RFRR

REFUSAL PROCESSED BY MPU

20/08/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/08/2024

CNRT

NON-FINAL ACTION WRITTEN

09/08/2024

DOCK

ASSIGNED TO EXAMINER

08/08/2024

MAFR

APPLICATION FILING RECEIPT MAILED

07/08/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/08/2024

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/08/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

25/07/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace K TREATMENTS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.